Use-of-Proceeds Gaps: Why VCs Discount Your Round
Why VCs discount rounds when your fundraise math does not match your milestones, and how to build a use-of-proceeds story that holds up.
On the surface, nothing seems outrageous. Then the diligence model starts to crack the story open.
The current burn is $250,000 per month. The proposed hiring plan adds another $450,000 per month within two quarters. Sales reps are assumed to ramp in three months, despite a six-month historical sales cycle. Gross margin is modeled at 78%, even though the company’s last two enterprise deployments ran at 61% once implementation labor is fully loaded. The milestone for the next round is “$4 million ARR,” but the implied burn to reach it leaves only five months of cash at the point the company would need to start fundraising again. Worse, if the ARR target slips by one quarter, the company lands in a bridge round with weak leverage.
The investors do not usually say, “Your use-of-proceeds model is incoherent, therefore we are cutting your valuation.” They say softer things.
“We like the business, but the pricing feels a little ahead of where the company is.”
“We’d be more comfortable leading at $36 million pre.”
“We think the round should be smaller, or the milestones need to be tighter.”
“Help us understand what milestone this amount of capital is truly buying.”
This is the use-of-proceeds credibility gap. It is one of the least discussed drivers of valuation compression in venture fundraising.
Founders often think valuation is set by market comps, growth rate, competitive heat, and investor demand. Those things matter. But sophisticated investors also price a round based on whether the amount being raised, the burn plan, the hiring roadmap, and the next-financing milestones form a coherent capital narrative. When they do not, investors quietly apply a haircut. Sometimes they cut valuation. Sometimes they cut ownership targets upward. Sometimes they push for tranche structures, pay-to-play protections, or heavier governance. But the root issue is the same: your financing story does not survive arithmetic.
The real problem is not sloppy budgeting. It is signaling.
A weak use-of-proceeds plan is not merely an operating flaw. It sends three dangerous signals to investors.
First, it signals poor capital efficiency discipline. If you are asking for capital without a precise theory for how dollars convert into de-risking, investors infer that future spending decisions may also be loose.
Second, it signals bridge risk. If the capital raised does not comfortably get the company to a credible next-round milestone with enough buffer to run a process, investors assume they may be forced into an inside round or an awkward extension.
Third, it signals fuzzy pricing discipline. If a founder wants a high valuation but cannot explain why this specific round size at this specific price creates a sensible ownership, runway, and milestone path, investors worry the founder is optimizing for optics instead of outcomes.
That last point matters more than founders realize. VCs know companies rarely execute exactly to plan. They are not looking for a perfect forecast. They are looking for whether the founder understands which variables actually matter and whether the plan has enough internal consistency to absorb inevitable misses.
A company that says, “We need $10 million because that gives us 24 months of runway” sounds superficially reasonable. But if the first nine months of spend are front-loaded hiring with limited short-term revenue impact, and the real milestone is not hit until month 21, then “24 months of runway” is not actually 24 months of financing safety. It is a company beginning a fundraising process with almost no room for error.
Investors hear that instantly.
Why current fundraising approaches fail
Most weak financing narratives fall into one of five traps.
1. Founders back into a round size from dilution tolerance instead of milestone cost
A founder decides they do not want to sell more than 20% in the round. From there, they pick the round size that preserves optics.
For example:
That may look neat, but it is backwards. The right sequence is:
When founders start from dilution preference, they often end up with round sizes too large for current traction or too small for meaningful de-risking. Both outcomes hurt valuation.
2. They confuse budget line items with milestone logic
A spreadsheet full of spend categories is not a financing strategy. Saying “40% product, 30% sales, 20% marketing, 10% G&A” is not persuasive unless those allocations map clearly to milestone creation.
VCs do not fund categories. They fund de-risking.
A strong use-of-proceeds plan says something like:
That is investable because each dollar is tied to a specific operational unlock.
3. They assume hiring instantly creates output
This is probably the most common issue in growth-stage fundraising models.
Engineers are treated as if they become productive on day one. Reps are treated as if they hit quota in one quarter. Marketing spend is treated as if CAC stays constant while volume scales.
None of that is how companies work.
Every hire has lag:
If your model shows six AEs hired in Q1 generating full contribution by Q2, investors will discount it automatically unless you have unusual evidence. In enterprise software, a more realistic assumption might be:
That timeline has major implications for runway and milestone timing.
4. They underwrite the next round as if capital markets are always open
Too many plans assume the next round can be raised right when the operating milestone is hit. In reality, fundraising takes time, and market windows can shut.
If your target is to raise a Series B once you reach $4 million ARR, and your plan hits that at month 18 with only 4 months of cash left, you do not actually have a clean Series B setup. You have a financing cliff.
Investors know this. So they discount today for the chance that they or someone else will need to rescue the company tomorrow.
5. They ignore gross-margin and working-capital sensitivity
Revenue is not enough. The quality of revenue matters.
If implementation-heavy enterprise contracts create delayed margin realization, or if inventory, hosting, or support costs rise with new customer mix, then the same ARR number may produce very different financing outcomes.
A company projected to hit $5 million ARR at 80% gross margin is a different fundraise than one hitting $5 million ARR at 58% gross margin with long deployment cycles and heavy services load.
Founders often model the former while operating like the latter.
That mismatch kills credibility fast.
The core insight: VCs discount incoherent rounds because valuation is a function of financing risk, not just company quality
Many founders treat valuation as a statement about the business. Investors treat it as a statement about expected return adjusted for risk, including financing path risk.
A round is not simply pricing your current company. It is pricing the probability that this amount of money, deployed under your plan, gets the company to a materially better future financing state.
If the plan lacks coherence, the investor has three bad options:
They usually choose option three.
This is why two companies with similar ARR, growth, and market quality can get very different prices. The one with the tighter financing narrative often commands a better valuation because investors can see exactly how today’s check creates tomorrow’s leverage.
In other words, use-of-proceeds credibility is not a presentation detail. It is a valuation variable.
The diligence tests investors actually use
Sophisticated funds run a set of practical tests to see whether your round math hangs together. Sometimes these are formal models. Sometimes they are quick partner-meeting mental math. Either way, they matter.
1. Cash runway modeling: How much real runway does this round buy?
This is not just current burn divided into cash raised. Investors rebuild the burn curve month by month.
They look at:
Let’s use an example.
Assume:
Founder claim: “This gives us roughly 24 months of runway.”
Now rebuild the plan.
Hiring over first 6 months:
Incremental burn once fully loaded: $304,000/month
So by month 7, monthly burn is closer to $604,000 before accounting for any revenue offset.
Suppose revenue improves net burn by only $80,000/month by month 9 because rep ramp is slower than planned. Real net burn becomes roughly $524,000/month.
A rough weighted burn path might look like:
Total over 24 months = $12.075 million
But you only had $10.9 million of cash post-close.
So your “24-month runway” is actually closer to 21 or 22 months, maybe less if collections slip or hiring happens faster than revenue.
VC conclusion: the founder’s headline runway claim is unreliable.
That alone can lower perceived valuation support.
2. Headcount timing test: Are hires sequenced to milestones or just ambition?
Investors ask whether headcount expansion is milestone-linked or merely aspirational.
Bad sequence:
Better sequence:
This is where founders often lose the room. A hiring plan can signal either operating discipline or empire-building.
Investors prefer plans where spend unlocks the next bottleneck, not where every function is scaled simultaneously.
A simple investor question captures this: if revenue slips 20% versus plan, which hires would you delay and what milestone would still be preserved?
If you cannot answer quickly, your use-of-proceeds logic is probably undercooked.
3. Sales ramp assumption test: Does go-to-market math match historical reality?
VCs compare your forward sales assumptions against actual funnel data.
They examine:
Suppose a startup has:
The fundraising model assumes four new AEs hired in Q1 produce $2.4 million in new ARR by year-end. That implies $600,000 per rep in the partial first year, despite no evidence that current reps consistently perform at that level.
A VC will haircut that instantly. Perhaps they re-underwrite to:
That one change may cut projected ARR at the financing milestone by $1.0 million or more. And if the next round depended on hitting $3.5 million ARR rather than $2.5 million ARR, the company’s financing risk rises sharply.
Again, today’s valuation comes down because tomorrow’s milestone confidence comes down.
4. Gross-margin sensitivity test: What if the revenue mix is worse than the deck says?
Investors often run upside/downside cases on gross margin because margin weakness amplifies financing needs.
Imagine a company projecting:
But actual evidence suggests recent customer cohorts include heavier onboarding and support. Investors may test scenarios at 70% and 65% gross margin.
At $5 million ARR:
That difference of $400,000 to $650,000 per year in gross profit matters because it changes burn, payback periods, and financing readiness.
If the company’s next-round story depends on demonstrating operating leverage, a lower-margin reality can push the company out of the “efficient growth” bucket and into the “capital-intensive scaling” bucket. Different investors, different terms, lower pricing.
5. Next-round readiness math: Will this round get the company to a fundable Series B, not just a milestone slide?
This is the most important test and the one founders underappreciate most.
Investors ask:
Suppose a company raises a Series A today.
Round terms:
Current metrics:
The company says the next round milestone is:
Investors build a readiness case:
So even if the company technically “gets there,” it may not get there in time, or with enough quality, to raise from strength.
A company that reaches milestone with 12 months of cash left is financeable. A company that reaches milestone with 4 months of cash left is vulnerable. Same ARR, different leverage.
That difference absolutely affects valuation today.
A cap table perspective: why investors care about round sizing discipline
Founders often underestimate how use-of-proceeds logic interacts with ownership math.
Let’s compare two scenarios.
Scenario A: The aspirational raise
Cap table before round:
Post-round approximate:
Looks acceptable. But if $15 million is more than the company can credibly deploy before the next milestone, investors may worry the company is overcapitalized at too early a stage. That can create pressure to spend into valuation rather than spend into discipline. Ironically, the larger round can hurt pricing support.
Scenario B: The milestone-calibrated raise
Post-round approximate:
At first glance, founders may dislike the lower pre-money. But if this smaller round is explicitly tied to a sharp de-risking milestone that can support a materially better Series B, founder outcomes may improve.
Imagine the company then raises a Series B at:
If Scenario B got the company there with less waste and better metrics, founders may own more value in absolute terms despite the lower A valuation.
The point is not that smaller rounds are always better. The point is that round size should match milestone cost and market timing. Investors punish companies that raise amounts disconnected from what the business can responsibly convert into leverage.
Where term sheets reflect the credibility gap
Investors do not always express their doubts through headline valuation alone. They often encode them in terms.
Lower pre-money with “supportive” messaging
The cleanest expression is simply a lower price.
Founder ask:
Investor response:
That is not just negotiating toughness. It may reflect an internal belief that the milestone path has too much slippage risk to justify the ask.
Tranching
If use-of-proceeds confidence is weak, investors may offer:
Founders usually dislike this for good reason. It introduces financing uncertainty and governance friction. But from the investor side, it is a direct response to doubts about capital deployment credibility.
Heavier protective provisions
An investor may accept the valuation but demand stronger controls:
These are governance solutions to a financing trust problem.
Larger option pool refresh before close
If the hiring plan is aggressive but the current option pool is insufficient, investors may push for a pre-money option pool expansion. Economically, this reduces effective founder pricing.
Example:
That pool expansion shifts dilution toward existing holders, lowering the founder’s true economics. Often this happens because the investor does not believe the original use-of-proceeds fully accounted for talent costs.
A negotiation scenario with real numbers
Consider a startup raising a $14 million Series A.
Founder proposal:
Diligence findings:
Investor counter:
Option 1:
Option 2:
Many founders instinctively prefer Option 1 because it preserves round size. But in practice, Option 2 may be healthier if $10 million actually aligns with the company’s true path to the next de-risking event.
A strong board discussion here is not “How do we protect the highest nominal pre?” It is “What capitalization and spend plan maximize the odds of reaching the next financing from strength?”
That is the right lens.
How founders can rebuild a coherent financing narrative
This is fixable. In fact, founders who present a disciplined, internally consistent use-of-proceeds plan can materially improve investor confidence even if they do not have perfect metrics.
1. Define the next round milestone in investor terms, not founder terms
Do not say: “We want to raise enough to keep growing.”
Say: “This round is designed to get us to a fundable Series B state defined by $X ARR, Y gross margin, Z retention, and evidence of repeatable acquisition economics, with at least 9 months of remaining runway at process launch.”
That framing shows you understand financing as a staged de-risking exercise.
2. Build the model from milestone backward, then stress-test it
Start with the milestone and ask:
Then show base, downside, and severe downside cases.
Counterintuitively, this increases confidence. Investors trust founders more when they show they understand fragility.
3. Sequence headcount to bottlenecks
Every planned hire should answer one question: what constraint does this remove?
Examples:
This is far more persuasive than broad org-chart ambition.
4. Separate “must-have” from “nice-to-have” spend
Create clear spending layers.
For instance:
Core plan:
Acceleration plan:
Contingency reserve:
This allows investors to evaluate whether the raise amount is tightly reasoned rather than padded.
5. Show next-round readiness math explicitly
This should be in every serious fundraising conversation.
Example:
That level of clarity is rare. It stands out.
6. Make valuation a consequence of the plan, not the starting point
When discussing pricing, anchor it to the capital story.
A strong line is: “We sized this round to reach a specific de-risking milestone with buffer. At this amount, we think a valuation in the X to Y range preserves enough ownership while still setting the company up for an efficient next financing.”
That sounds materially more credible than “We are targeting a $50 million pre because that is where strong Series As are clearing.”
A practical founder checklist before you go to market
Before fundraising, be able to answer these without hand-waving:
If those answers are weak, investors will sense it quickly. They may still invest. But they will price the uncertainty.
The contrarian takeaway
Founders are often told that confidence sells, that big vision wins, and that investors fund momentum. True, up to a point. But in real partner rooms, quiet mathematical inconsistency destroys more pricing power than most founders realize.
The best fundraising narratives are not the most expansive. They are the most internally coherent.
If your round size is too big relative to milestone needs, investors worry you will spend loosely.
If it is too small relative to execution risk, investors worry you will be back too soon.
If your hiring plan outruns your sales evidence, they discount your forecast.
If your revenue milestone ignores gross-margin reality, they discount your operating leverage.
If your next-round timeline leaves no fundraising buffer, they discount your bargaining position in advance.
That is the use-of-proceeds credibility gap. It is not usually discussed explicitly. It is simply embedded into pricing, terms, and conviction.
The founders who outperform in fundraising are not always the ones with the hottest deck. They are the ones who can prove that capital amount, valuation, burn plan, hiring sequence, and milestone timing all fit together as one system.
When that system is coherent, investors lean in.
When it is not, they do not debate your spreadsheet cell by cell. They just pay less.
RaiseSimpli Team
Author